ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - FRA:ACT - DE000A2YNT30 - Common Stock
166.6 EUR
+4.6 (+2.84%)
We assign a fundamental rating of 7 out of 10 to ACT. ACT was compared to 69 industry peers in the Chemicals industry. ACT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACT is quite expensive at the moment. It does show a decent growth rate. These ratings would make ACT suitable for quality investing!
1. Profitability
1.1 Basic Checks
ACT had positive earnings in the past year.
In the past year ACT had a positive cash flow from operations.
In the past 5 years ACT has always been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.48%, ACT belongs to the top of the industry, outperforming 94.20% of the companies in the same industry.
ACT has a better Return On Equity (26.66%) than 98.55% of its industry peers.
The Return On Invested Capital of ACT (13.72%) is better than 94.20% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACT is significantly above the industry average of 7.01%.
The last Return On Invested Capital (13.72%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROIC | 13.72% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
Looking at the Profit Margin, with a value of 10.43%, ACT is in the better half of the industry, outperforming 79.71% of the companies in the same industry.
ACT's Profit Margin has improved in the last couple of years.
The Operating Margin of ACT (15.34%) is better than 85.51% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
ACT has a better Gross Margin (65.74%) than 97.10% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
ACT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACT has less shares outstanding
The debt/assets ratio for ACT has been reduced compared to a year ago.
2.2 Solvency
ACT has an Altman-Z score of 5.25. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ACT (5.25) is better than 91.30% of its industry peers.
The Debt to FCF ratio of ACT is 1.15, which is an excellent value as it means it would take ACT, only 1.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.15, ACT belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that ACT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, ACT is doing good in the industry, outperforming 69.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 5.25 |
ROIC/WACC1.91
WACC7.19%
2.3 Liquidity
A Current Ratio of 2.84 indicates that ACT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.84, ACT belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
ACT has a Quick Ratio of 1.73. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
ACT has a better Quick ratio (1.73) than 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.03% in the past year.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
3.2 Future
Based on estimates for the next years, ACT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.37% on average per year.
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.18 indicates a quite expensive valuation of ACT.
ACT's Price/Earnings is on the same level as the industry average.
ACT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 24.30 indicates a rather expensive valuation of ACT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT indicates a slightly more expensive valuation: ACT is more expensive than 60.87% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.52. ACT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.18 | ||
| Fwd PE | 24.3 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACT is valued a bit more expensive than 60.87% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.01 | ||
| EV/EBITDA | 15.06 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.32% in the coming years.
PEG (NY)1.67
PEG (5Y)1.19
EPS Next 2Y16.02%
EPS Next 3Y19.32%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 1.11%.
Compared to an average industry Dividend Yield of 3.18, ACT is paying slightly less dividend.
With a Dividend Yield of 1.11, ACT pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.11% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
31.40% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.4%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
FRA:ACT (10/31/2025, 7:00:00 PM)
166.6
+4.6 (+2.84%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.70B
Revenue(TTM)555.53M
Net Income(TTM)57.92M
Analysts81.82
Price Target161.52 (-3.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.11% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.18 | ||
| Fwd PE | 24.3 | ||
| P/S | 3.05 | ||
| P/FCF | 41.01 | ||
| P/OCF | 15.07 | ||
| P/B | 7.8 | ||
| P/tB | 7.94 | ||
| EV/EBITDA | 15.06 |
EPS(TTM)5.71
EY3.43%
EPS(NY)6.86
Fwd EY4.12%
FCF(TTM)4.06
FCFY2.44%
OCF(TTM)11.06
OCFY6.64%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.67
PEG (5Y)1.19
Graham Number52.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROCE | 19.03% | ||
| ROIC | 13.72% | ||
| ROICexc | 16.02% | ||
| ROICexgc | 16.17% | ||
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% | ||
| FCFM | 7.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 270.53% | ||
| Cap/Sales | 12.82% | ||
| Interest Coverage | 42.05 | ||
| Cash Conversion | 100.91% | ||
| Profit Quality | 71.41% | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 5.25 |
F-Score7
WACC7.19%
ROIC/WACC1.91
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 29.18 and the Price/Book (PB) ratio is 7.8.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.